The U.S., Italy and Japan accounted for more than 60% of physicians who held strong opinions on whether patients should have the option to choose between branded or generic drugs.
Selarsdi (ustekinumab-aekn) injection for subcutaneous use is for the treatment of moderate to severe plaque psoriasis and for active psoriatic arthritis.
Upsher-Smith has broadened its offerings to include Vigadrone (vigabatrin) Tablets, 500 mg. Torpenz Tablets, a branded-generic everolimus tablet, will soon be available to prescribers and patients.